Frank Pallone Jr. tweeted the following:
"The spending bill also includes provisions from my @EnergyCommerce to strengthen FDAs ability to approve drugs that are put on the market through the accelerated approval pathway. It clarifies FDAs authority to withdraw approvals where sponsors fail to conduct proper studies."Read on Twitter
Here are other recent tweets from Frank Pallone Jr.:
"The government funding bill that Congress passed last week includes provisions from my @EnergyCommerce to improve both research and the drug approval process. It establishes an advance research entity (ARPA-H) that will accelerate innovation in health and medicine." on Dec. 29Read on Twitter
"While we all support the search for new cures and treatments to address devastating diseases like Alzheimers, we must ensure that expediency does not take precedence over scientific rigor and patient safety. I'm hopeful this report will help us all improve going forward." on Dec. 29Read on Twitter
"Today I released the findings of an 18-month joint @EnergyCommerce and @OversightDems investigation into the controversial review, approval, and pricing of the Alzheimer's disease drug Aduhelm. energycommerce.house.gov/newsroom/press" on Dec. 29Read on Twitter
Alerts Sign-up